Keywords: مهارکنندههای بازجذب سروتونین; MDD; major depressive disorder; PIC; proinflammatory cytokine; AIC; anti-inflammatory cytokine; HC; hippocampus; LTP; long term potentiation; HPA; hypothalamus-pituitary-adrenal; 3-HK; 3-hydroxykynurenine; QA; quinolinic acid; IDO; indoleamine-2,3-dioxyge
مقالات ISI مهارکنندههای بازجذب سروتونین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهارکنندههای بازجذب سروتونین; 5-HIAA; 5-hydroxyindoleacetic acid; 5-HT-5; hydroxytryptamine; ACC; anterior cingulate cortex; AMYG; amygdala; BDNF; brain derived neurotrophic factor; dlPFC; dorsolateral prefrontal cortex; dmPFC; dorsomedial prefrontal cortex; DNA; deoxyribonucleic acid
Keywords: مهارکنندههای بازجذب سروتونین; 5-HT; serotonin; ACTH; adrenocorticotropic hormone; BDNF; brain-derived neurotrophic factor; BLA; basolateral amygdala; CpG; cytosine phosphate guanosine; CREB; cAMP response element-binding protein; GR; glucocorticoid receptor; HAT; histone acetyltransfe
Keywords: مهارکنندههای بازجذب سروتونین; ACTH; adrenocorticotropic hormone; ATP; adenosine triphosphate; BD; bipolar depression; BDNF; brain derived neurotrophic factor; BP; bipolar disorder; CMUS; chronic mild unpredictable stress; CUS; chronic unpredictable stress; CRH; corticotropin releasing
Keywords: مهارکنندههای بازجذب سروتونین; ACC; anterior cingulate cortex; AMPA; alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionic acid; BDNF; brain-derived neurotrophic factor; CaMKII; Ca2+/calmodulin-dependent protein kinase II; cAMP; cyclic adenosine monophosphate; CREB; cAMP-response elemen
Keywords: مهارکنندههای بازجذب سروتونین; Obsessive-compulsive disorder; OCD; Pharmacotherapy; SSRI; Antidepressant; Augmentation;
Keywords: مهارکنندههای بازجذب سروتونین; Prostaglandin; Stomach; Side Effects; Treatment; AP; proportion attributable to interaction; ATC; Anatomical Therapeutic Chemical; CI; confidence interval; COX-2 inhibitor; cyclooxygenase-2 selective inhibitor; EHR; electronic health record; GPA; gastropr
Keywords: مهارکنندههای بازجذب سروتونین; 2-AG; 2-arachidonylglycerol; 5-HT; 5-hydroxytryptamine; ACC; anterior cingulate cortex; AEA; anandamide; AMPA; alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; CB1; cannabinoid receptor 1; CB2; cannabinoid type 2; CCK; cholecystokinin; CCK2; chol
Keywords: مهارکنندههای بازجذب سروتونین; AGA; American Gastroenterological Association; CI; confidence interval; CSBM; complete spontaneous bowel movement; FDA; Food and Drug Administration; GRADE; Grading of Recommendations Assessment, Development and Evaluation; IBS; irritable bowel syndrome;
Keywords: مهارکنندههای بازجذب سروتونین; 5-HT; 5-hydroxytryptamine (serotonin); 5-HTP; 5-hydroxytryptophan; ACh; acetylcholine; AHP; afterhyperpolarization; BK; big potassium channel; Cai; internal calcium ion concentration; CB; calbindin-D28k; CBP; calcium binding protein; CDI; calcium-dependen
Keywords: مهارکنندههای بازجذب سروتونین; Ach; acetylcholine; AchE; acetylcholine esterease; ACTH; adrenocorticotrophic hormone; ADHD; attention deficit/hyperactivity disorder; AIDS; autoimmune deficiency syndrome; AMSH; alpha-melanocyte-stimulating hormone; BAM; bovine adrenal medulla peptide; B
Keywords: مهارکنندههای بازجذب سروتونین; SERT; serotonin transporter; NET; norepinephrine transporter; DAT; dopamine transporter; NSS; neurotransmitter/sodium (Na+/Clâ) symporter; SSRI; selective serotonin reuptake inhibitor; NBD; nitrobenzoxadiazolealanine; NMM; N-methylmorpholine; NHS; N-hyd
Keywords: مهارکنندههای بازجذب سروتونین; Paroxetine; Hypersomnia; SSRI; Beneficial pharmacological effect; Genetic polymorphisms;
Keywords: مهارکنندههای بازجذب سروتونین; SSRI; Sertraline; Citalopram; Fluoxetine; Propranolol; Beta blocker; Dichotic listening;
Keywords: مهارکنندههای بازجذب سروتونین; MDD; major depressive disorder; BMD; bone mineral density; SSRI; selective serotonin reuptake inhibitor; BMI; body mass index; OPG; osteoprotegerin; IPAQ; International Physical Activity Questionnaire; CRP; C-reactive protein; IL-6; interleukin-6; RANKL;
Keywords: مهارکنندههای بازجذب سروتونین; IL-6; interleukin-6; TNF-α; tumor necrosis factor- alpha; BMI; body mass index; MDD; major depressive disorder; MDD-M; major depressive disorder with melancholic features; MDD-A; major depressive disorder with atypical features; IL-1β; Interleukin-1be
Keywords: مهارکنندههای بازجذب سروتونین; OCD; obsessive compulsive disorder; CCD; canine compulsive disorder; SSRI; selective serotonin reuptake inhibitors; TCA; tricyclic anti-depressants; PET; positron emission tomography; NMDA; N-Methyl-D-aspartate; OFC; orbitofrontal cortex; ACC; anterior ci
Keywords: مهارکنندههای بازجذب سروتونین; GAD; Generalized anxiety disorder; CON; Control group; GAD-p group; GAD-pharmacotherapy; GAD group; Generalized anxiety disorder group; CBT; cognitive behavioral therapy; SSRI; selective serotonin reuptake inhibitor; SCID-P; Structured Clinical Interview
Keywords: مهارکنندههای بازجذب سروتونین; SSRI; Selective serotonin reuptake inhibitor; SRI; serotonin reuptake inhibitor; BSID III; Bayley Scale of Infant Development Third edition; EPDS; Edinburgh Postnatal Depression Scale; HAMD; Hamilton Rating Scale for Depression; PA; Positive Affect; Serot
Keywords: مهارکنندههای بازجذب سروتونین; ACTH; Adrenocorticotropic hormone; ANOVA; Analysis of variance; ANS; Autonomic nervous system; CgA; Chromogranin A; Dex/CRH; Combined dexamethasone suppression/corticotropin releasing hormone stimulation test; DSM-IV; Diagnostic and Statistical Manual of
Keywords: مهارکنندههای بازجذب سروتونین; SSRI; selective serotonin reuptake inhibitors; TCA; tricyclic antidepressant; ECT; electroconvulsive therapy; RCT; randomized controlled trial; OR; odds ratio; FDA; Food and Drug Administration; DSM-IV; Diagnostic and Statistical Manual of Mental Disorder
Keywords: مهارکنندههای بازجذب سروتونین; BDZ; benzodiazepinic; BUSP; buspirone; CA; carvacryl acetate; DZP; diazepam; EPM; elevated plus-maze test; EL; epoxy-limonene; FLU; flumazenil; GABA; gamma-aminobutyric acid; LDB; light-dark box test; MBT; marble-burying test; NF; number of falls; NELB;
Keywords: مهارکنندههای بازجذب سروتونین; 5-HTTLPR; Antidepressant; SSRI; Meta-analysis; Discontinuation;
Keywords: مهارکنندههای بازجذب سروتونین; Solute carrier; SLC; Clinical trials; SSRI; Drug target;
Keywords: مهارکنندههای بازجذب سروتونین; Antidepressant; Low/high activity; SSRI; SNRI; Rat; Estrous cycle;
Keywords: مهارکنندههای بازجذب سروتونین; AgRP; agouti-related protein; ANOVA; analysis of variance; b-FGF; basic fibroblast growth factor; BMI; body mass index; BTC; betacellulin; CI; Confidence interval; CRF; corticotropin-releasing factor; CRP; C reactive protein; CTE; childhood trauma exposur
Keywords: مهارکنندههای بازجذب سروتونین; PMDD; premenstrual dysphoric disorder; PWD; progesterone withdrawal; FST; forced swim test; 5-HT; serotonin; SSRI; selective serotonin reuptake inhibitor; SNRI; serotonin norepinephrine reuptake inhibitor; SERT; serotonin transporter; AMI; amitriptyline;
Keywords: مهارکنندههای بازجذب سروتونین; ACC; anterior cingulate cortex; AC-PC; anterior commissure-posterior commissure; ANCOVA; analysis of covariance; ASSET; array spatial sensitivity encoding techniques; BA; Brodmann area; BDI; Beck Depression Inventory; CSF; cerebrospinal fluid; DTI; Di
Keywords: مهارکنندههای بازجذب سروتونین; CNS; central nervous system; DAT; dopamine transporter; GABA; gamma-aminobutyric acid; GAT; gamma-aminobutyric acid (GABA) transporter; GLT; glutamate transporter; iDAT; invertebrate dopamine transporter; NAT; noradrenaline transporter; NTT; neurotransmit
Keywords: مهارکنندههای بازجذب سروتونین; HPA; hypothalamic-pituitary-adrenal; LPS; lipopolysaccharide; COR; corticosterone; SSRI; selective serotonin reuptake inhibitor; FLX; fluoxetine; PND; postnatal day; OF; open field; IZT; inner zone time; IZE; inner zone entries; EPM; elevated plus-maze; O
Keywords: مهارکنندههای بازجذب سروتونین; LPS; lipopolysaccharide; HPA; hypothalamic-pituitary-adrenal; PND; postnatal day; FLX; fluoxetine; SSRI; selective serotonin reuptake inhibitor; COR; corticosterone; FST; forced swimming test; TST; tail suspension test; ANOVA; analysis of variance; NP
Keywords: مهارکنندههای بازجذب سروتونین; SSRI; Depression; Hypothalamus; Sexual differentiation; Development; Antidepressant medication; Prenatal stress; Reproduction; Maternal depression;
Keywords: مهارکنندههای بازجذب سروتونین; APIs; active pharmaceutical ingredients; FDA; U.S. Food and Drug Administration; ADRs; adverse drug reactions; DDD; defined daily dose; PBT; persistent, bioaccumulative, toxic; SSRI; selective serotonin reuptake inhibitor; Active pharmaceutical ingredient
Keywords: مهارکنندههای بازجذب سروتونین; SSRI; Antidepressants; Inflammation; Inflammatory; Neuroinflammation; Neuroinflammatory; Pro-inflammatory; Cytokines; Anti-inflammatory; Reuptake inhibitor; Depression; Monoamine; Monoamine theory;
Keywords: مهارکنندههای بازجذب سروتونین; Antidepressants; SSRI; NRI; Serotonin; Noradrenalin; Emotion; fMRI; Multi-Level Kernel Density Analysis; Meta-analysis;
Keywords: مهارکنندههای بازجذب سروتونین; ACh; acetylcholine; ADHD; attention deficit hyperactivity disorder; ANOVA; analysis of variance; BSA; bovine serum albumin; CNS; central nervous system; DA; dopamine; dr; dose ratio; FDA; United States Food and Drug Administration; nAChR; nicotinic acetyl
Keywords: مهارکنندههای بازجذب سروتونین; mPFC; medial prefrontal cortex; ACC; anterior cingulate cortex; DG; dentate gyrus; NAc; nucleus accumbens; AMPAR; α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor; NMDAR; N-methyl-d-aspartic acid receptor; VDCC; voltage-dependent calcium ch
Keywords: مهارکنندههای بازجذب سروتونین; Aβ; amyloid β; AADC; L-amino acid decarboxylase; ACC; Anterior cingulate cortex; AD; Alzheimer's disease; aMCI; Amnestic mild cognitive impairment; APP; Amyloid precursor protein; AR; Adrenergic receptor; ATMX; atomoxetine; BDNF; Brain-derived neurotrop
Keywords: مهارکنندههای بازجذب سروتونین; Depression; SSRI; Healthcare services; Medication adherence; Sick leave;
Keywords: مهارکنندههای بازجذب سروتونین; Hispanic; Latino/a; Major Depressive Disorder; Quality of Life; Functioning; SSRI;
Keywords: مهارکنندههای بازجذب سروتونین; SSRI; pregnancy; offspring depression; ASD; ADHD
Keywords: مهارکنندههای بازجذب سروتونین; Fluoxetine; Glucocorticoid resistance; Restraint stress; SSRI; Major depression disorder; HPA axis
Keywords: مهارکنندههای بازجذب سروتونین; SSRI; Prenatal stress; Neuroplasticity; Hippocampus; Postpartum depression; Serotonin; Epigenetic; Maternal behavior; Sex differences; Gender
Keywords: مهارکنندههای بازجذب سروتونین; maternal drug use; neonatal abstinence syndrome; non‐opioid; opioid; SSRI
Les hyponatrémies sous ISRS/IRSNA : étude épidémiologique descriptive et comparative des taux d'incidence de cas notifiés à partir des données de la Banque nationale de pharmacovigilance et de l'Assurance maladie
Keywords: مهارکنندههای بازجذب سروتونین; Hyponatrémie; ISRS; IRSNA; Ãtude pharmacoépidémiologique; Hyponatremia; SSRI; SNRI; Pharmacoepidemiological study;
Acid-sensing T cell death associated gene-8 receptor expression in panic disorder
Keywords: مهارکنندههای بازجذب سروتونین; pH; Panic; TDAG8; Expression; PDSS; SSRI; Treatment;
TMEM16F/ANO6, a Ca2+-activated anion channel, is negatively regulated by the actin cytoskeleton and intracellular MgATP
Keywords: مهارکنندههای بازجذب سروتونین; Anoctamin 6; TMEM16F; Calcium activated Clâ current; Actin cytoskeleton; Magnesium ATP; ANO; anoctamin; NMDG-Cl; N-methyl-d-glucamine-Cl; SSRI; serotonin-specific reuptake inhibitor;
Doxazosin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in military veterans
Keywords: مهارکنندههای بازجذب سروتونین; Posttraumatic stress disorder; PTSD; Alcohol; Substance use disorder; Military; Veterans; AMY; amygdala; AUD; alcohol use disorder; BAM; Brief Addiction Monitor; BP; blood pressure; CAP; Consortium to Alleviate PTSD; CAPS-5; Clinician-Administered PTSD Sc
Single Fluid-Filled Intragastric Balloon Safe and Effective for Inducing Weight Loss in a Real-World Population
Keywords: مهارکنندههای بازجذب سروتونین; SF-IGB; SNRI; SSRI; Overweight; Bariatric Surgery; Obesity; Balloon; Endoscopy; BMI; body mass index; FDA; Food and Drug Administration; OIB; Orbera intragastric balloon; SNRI; serotonin-norepinephrine re-uptake inhibitor; SSRI; selective serotonin re-
Acute and chronic escitalopram alter EEG gamma oscillations differently: relevance to therapeutic effects
Keywords: مهارکنندههای بازجذب سروتونین; Antidepressant; SSRI; Pharmaco-EEG; Gamma power; Rat; Side effects; Depression;